MeMed Severity
Risk Stratification for Acute Infection Deterioration
CE‑marked / FDA‑clearance pendingActive
Key Facts
Indication
Risk Stratification for Acute Infection Deterioration
Phase
CE‑marked / FDA‑clearance pending
Status
Active
Company
About MeMed
MeMed delivers FDA‑cleared, 15‑minute host‑immune response tests that differentiate bacterial and viral infections, supporting better clinical decisions.
View full company profile